AstraZeneca PLC
1374.50
06-May-25 11:29:50
15 minutes delayed
Stocks
-17.00
-1.22%
Today's range
1369.50 - 1406.00
ISIN
N/A
Source
NASD.OMX SE
-
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases
30 Aug 2024 09:35:45 By NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
30 Aug 2024 06:41:41 By NetDania Notify
-
Interesting AZN Put And Call Options For November 15th
23 Aug 2024 11:14:24 By NASDAQ Stocks
-
AZN: Enhertu Gets US Breakthrough Therapy Designation For HER2 Low/Ultralow Metastatic Breast Cancer
19 Aug 2024 03:08:28 By NASDAQ US Markets
-
AstraZeneca's Imfinzi Gets US Approval For Resectable Early-stage Lung Cancer
16 Aug 2024 03:28:46 By NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
16 Aug 2024 03:17:04 By NetDania Notify
-
AstraZeneca (AZN) Imfinzi Combo Gets EU Nod for Uterine Cancer
15 Aug 2024 07:38:12 By NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
15 Aug 2024 03:15:16 By NetDania Notify
-
NetDania - New 12 months High: AstraZeneca PLC
13 Aug 2024 03:19:30 By NetDania Notify
-
Ex-Dividend Reminder: Cencora, AstraZeneca and Wells Fargo
07 Aug 2024 10:27:01 By NASDAQ Stocks
-
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
04 Aug 2024 10:42:17 By NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
29 Jul 2024 08:07:19 By NetDania Notify
-
AstraZeneca: Calquence Combo Enhances PFS In First-Line CLL In Phase III Trial
29 Jul 2024 03:38:02 By NASDAQ US Markets
-
AstraZeneca Reports ODAC's Review Of Imfinzi - Quick Facts
26 Jul 2024 03:05:05 By NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
25 Jul 2024 03:15:03 By NetDania Notify
-
AstraZeneca Q2 Profit Rises, Lifts FY24 Outlook
25 Jul 2024 02:51:34 By NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
23 Jul 2024 06:15:26 By NetDania Notify
-
NetDania - New 12 months High: AstraZeneca PLC
22 Jul 2024 08:17:57 By NetDania Notify
-
Interesting AZN Put And Call Options For August 23rd
03 Jul 2024 13:16:51 By NASDAQ US Markets
-
AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer
01 Jul 2024 03:09:21 By NASDAQ US Markets